TLC Determination of Cyclophosphamide Degradation Products in Parent Substance and Drug Preparations

Pharmaceutical Chemistry Journal - Tập 37 - Trang 210-213 - 2003
A. P. Arzamastsev1, M. S. Goizman2, A. N. Grishina1, I. Yu. Krivtsova2, N. S. Tsyplyaeva2, T. Kh. Chibilyaev3
1Sechenov Medical Academy, Moscow, Russia
2State Scientific Center of the Russian Federation, Research Institute of Organic Semiproducts and Dyes, Moscow, Russia
3LENSfarm Company, Moscow, Russia

Tài liệu tham khảo

M. D. Mashkovskii, Drugs [in Russian], Meditsina, Moscow Meditsina (2000), Vol. 2, pp. 404, 409. Pharmacopoeial Article FS 42-2026–92. Cyclophosphan. USSR State Pharmacopoeia, Xth Ed. [in Russian], Meditsina, Moscow (1968), pp. 223, 235. Pharmacopoeial Article FS 42-2026–99. Cyclophosphan powder, 0.1 and 0.2 g, for injections. Pharmacopoeial Article Project FS 42-0046–1107–01. Cyclophosphan-LENS fast-soluble lyophilized, 0.1 and 0.2 g, for injections. Modification No. 1 to Pharmacopoeial Article FS 42-2026–99. Cyclophosphan. Pharmacopoeial Article FS 42-2026–99. Cyclophosphan. British Pharmacopoeia (1998), pp. 417, 1617. United Sates Pharmacopoeia. The National Formulary (24th Ed.), US Pharmacopoeial Convention, Rockville (2000), pp. 440–442.